To include your compound in the COVID-19 Resource Center, submit it here.

Analyst picks & changes

Analyst picks & changes

Analyst picks & changes
Company Bank Analyst Coverage Opinion
AtheroGenics (AGIX) Lazard Joel Sendek Price target Buy
Needham Mark Monane New Underperform
Sendek raised his target to $71 from $27 to reflect the value of

Read the full 399 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE